Ono Pharmaceutical Co., Ltd.
4528.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥753,691 | ¥1,185,087 | ¥4,049,393 | ¥4,566,887 |
| - Cash | ¥204,567 | ¥166,141 | ¥96,135 | ¥69,112 |
| + Debt | ¥146,678 | ¥8,862 | ¥9,168 | ¥8,802 |
| Enterprise Value | ¥695,802 | ¥1,027,808 | ¥3,962,426 | ¥4,506,577 |
| Revenue | ¥486,871 | ¥502,672 | ¥447,187 | ¥361,361 |
| % Growth | -3.1% | 12.4% | 23.8% | – |
| Gross Profit | ¥338,921 | ¥375,546 | ¥337,125 | ¥267,850 |
| % Margin | 69.6% | 74.7% | 75.4% | 74.1% |
| EBITDA | ¥91,540 | ¥182,103 | ¥161,896 | ¥122,827 |
| % Margin | 18.8% | 36.2% | 36.2% | 34% |
| Net Income | ¥50,047 | ¥127,977 | ¥112,723 | ¥80,519 |
| % Margin | 10.3% | 25.5% | 25.2% | 22.3% |
| EPS Diluted | 106.41 | 266.6 | 230.79 | 162.16 |
| % Growth | -60.1% | 15.5% | 42.3% | – |
| Operating Cash Flow | ¥82,459 | ¥110,660 | ¥159,610 | ¥61,829 |
| Capital Expenditures | -¥7,990 | -¥20,829 | -¥14,497 | -¥12,277 |
| Free Cash Flow | ¥74,469 | ¥89,831 | ¥145,113 | ¥49,552 |